Mark E Saad

AXSM

Mark E Saad serves as Director at Axsome Therapeutics, Inc. (AXSM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$110.5K

Total Sells

2 trades

$7.35M

Net Position

Net Seller

$7.24M

Companies Traded

AXSM

Active Period

Nov 2021 – Dec 2025

3 total trades

Most Recent

Sell AXSM

Dec 31, 2025 · $6.21M

Mark E Saad's Insider Trading at Axsome Therapeutics, Inc. (AXSM)

Buys

1 · $110.5K

Sells

2 · $7.35M

Total Shares Bought

3,200

Total Shares Sold

46,704

AXSM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 31, 2025	Sell	37,577	$165.18	$6.21M
Sep 5, 2025	Sell	9,127	$125.07	$1.14M
Nov 17, 2021	Buy	3,200	$34.53	$110.5K

Related Insiders

JEFFS ROGER

Director

AXSMSell · Jun 11, 2026

Susan Mahony

director

AXSMSell · Jun 10, 2026

Mark Coleman

Director

AXSMSell · Jun 10, 2026

TABUTEAU HERRIOT

director, 10 percent owner, officer: Chief Executive Officer

AXSMSell · Jun 9, 2026

Nick Pizzie

officer: Chief Financial Officer

AXSMSell · Jun 9, 2026

Mark L. Jacobson

officer: Chief Operating Officer

AXSMSell · May 5, 2026

Ari Maizel

officer: Chief Commercial Officer

AXSMSell · Apr 23, 2026

Hunter R. Murdock

General Counsel

AXSMSell · Jun 20, 2025

Explore More Insider Trading Data

AXSM Insider Trading Activity

View all insider trades at Axsome Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity